Hi, what are you looking for?
Jewish Business News
Search results for "Teva Pharmaceutical"
Business
"Reuters" said the settlement would be the largest ever paid over allegations of delaying generic drugs.
Politics
Dressed white lab coats, the protesters called for a boycott of the Israeli generic drugmaker TEVA.
Business
Teva’s American Depositary Receipts rose 2.2 percent to $63.31, giving it a market value of just under $54 billion.
Business
It's tictoc, tictoc, for Teva.
Business
Teva is selling four targeted oncology development programs to Ignyta for 6% of the biotech company.
Business
"Mr. Rabinovich's recent purchase of XTL shares in the market and his investment in InterCure is a resounding vote of confidence from our largest...
Business
Teva says that the move is designed to reduce its finance costs.
Money
The former president and CEO Teva Americas Generics earned $7.3 million in 2014.
Business
Copaxone’s patent remains in force at least until the Federal Circuit Appeals Court reconsiders the case. The rivals of Teva Pharmaceutical Industries Ltd. (NYSE:...
Business
Berenberg analysts see insurance companies pressuring MS patients to switch to generic versions of Copaxone. Last year, Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE:...